Comparison · NCT05965427-d6882072
PLWHIV and Mpox Coinfection vs HIV Negative PrEP Users With Mpox Infection: Severe Mpox Lesions
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. PLWHIV and Mpox Coinfection vs HIV Negative PrEP Users With Mpox Infection: Severe Mpox Lesions. Trial comparisons, record NCT05965427-d6882072. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT05965427-d6882072
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.00783 | 0.00359 | 0.017 | wilson | |
| Risk in group 2 | 0.00221 | 0.000606 | 0.00801 | wilson | |
| Risk difference, group 1 minus group 2 | 0.00563 | -0.00156 | 0.0149 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 3.55 | 0.718 | 17.5 | log | |
| Odds ratio, group 1 over group 2 | 3.57 | 0.718 | 17.7 | log | |
| Number needed to treat, for one more participant with the outcome on PLWHIV and Mpox Coinfection than on HIV Negative PrEP Users With Mpox Infection | 178 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | PLWHIV and Mpox Coinfection | People living with HIV (PLWHIV) who are at least 18 years of age, with confirmed MPX infection by documented, positive result on PCR testing of lesions from 1st May 2022 to 1st December 2023. | 6 | 766 | OG000 |
| Group 2 | HIV Negative PrEP Users With Mpox Infection | PrEP (Pre-exposure prophylaxis) users who are at least 18 years of age, with confirmed MPX infection by documented, positive result on PCR testing of lesions from 1st May 2022 to 1st December 2023. | 2 | 906 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Severe Mpox Lesions
- Description
The number of participants with severe Mpox lesions. Severity of lesions will be assessed by the peak number of lesions and peak number of sites. Participants with ≥100 lesions at peak severity will be classified as having severe lesions.
- Time frame
- From date of disease onset (first symptom) until date of peak number of lesions and sites recorded (up to 3 months)
- Population
- Skin lesion severity could not be analysed for all participants as the number of lesions were not available due to the retrospective data collection nature of this study.
Source ClinicalTrials.gov
Trial
- Title
- Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIV
- NCT number
- NCT05965427
- Phases
- Conditions
- Monkeypox, HIV Coinfection
- Interventions
- No intervention
- Lead sponsor
- NEAT ID Foundation
- Results first posted
- 2025-08-13
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT05965427?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT05965427-d6882072